Claim 70% Off TipRanks Premium
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Stay ahead of the market with the latest news and analysis and maximize your portfolio's potential
An announcement from Oramed Pharm ( (ORMP) ) is now available.
On July 22, 2025, Oramed Pharmaceuticals Inc. entered into an option agreement with Scilex Holding Company granting Scilex the right to repurchase warrants held by Oramed to buy a total of 6,500,000 shares of Scilex common stock at a nominal exercise price, in two tranches, for an agreed aggregate purchase price of $27 million. Scilex repurchased the first tranche of warrants covering 3,130,000 shares on September 30, 2025 for $13 million following a $750,000 option fee, and on December 30, 2025 completed the second and final tranche for the remaining 3,370,000 warrants for $14 million, plus a further $750,000 option fee, resulting in Oramed receiving total cash proceeds of $28.5 million from the transaction, bolstering its liquidity and financial flexibility.
The most recent analyst rating on (ORMP) stock is a Hold with a $3.00 price target. To see the full list of analyst forecasts on Oramed Pharm stock, see the ORMP Stock Forecast page.
Spark’s Take on ORMP Stock
According to Spark, TipRanks’ AI Analyst, ORMP is a Neutral.
The score is mainly supported by a strong, low-debt balance sheet and improving technical trend signals. Offsetting this are weak underlying operations and continued cash burn, which limit how much weight can be placed on the low P/E. Corporate actions (buyback) are a modest positive, but the JV termination adds execution risk.
To see Spark’s full report on ORMP stock, click here.
More about Oramed Pharm
Oramed Pharmaceuticals Inc. operates in the biopharmaceutical sector, focusing on the development and commercialization of oral drug delivery solutions. The company’s strategic activities include managing and monetizing equity and warrant positions in other healthcare companies as part of its broader capital allocation and financing strategy.
Average Trading Volume: 178,574
Technical Sentiment Signal: Buy
Current Market Cap: $115.8M
Learn more about ORMP stock on TipRanks’ Stock Analysis page.